The Bulletin of Pharmaceutical Sciences and Pharmacy adheres to the principles and best practices set forth by the Committee on Publication Ethics (COPE) and the recommendations of the International Committee of Medical Journal Editors (ICMJE). The journal is committed to upholding the highest standards of ethical conduct, academic integrity, and scientific quality in all aspects of the publication process.

All submitted manuscripts must represent original work that has not been previously published or simultaneously submitted elsewhere. Research involving human participants or animals must comply with internationally accepted ethical standards and include appropriate institutional review board or ethics committee approval, as well as informed consent where applicable.

The journal employs a rigorous, confidential peer-review process conducted by independent experts in the relevant fields. Editorial decisions are based solely on the scientific merit, originality, methodological soundness, and relevance of the work, without discrimination or conflict of interest.

Authorship must meet the criteria defined by the ICMJE, and all authors are responsible for the accuracy and integrity of the submitted work. Any potential conflicts of interest, funding sources, or financial relationships must be fully disclosed. The journal maintains a strict policy against plagiarism, duplicate publication, data fabrication, and data falsification, in accordance with COPE guidelines.

The Bulletin of Pharmaceutical Sciences and Pharmacy supports transparency and accountability in scholarly publishing. When necessary, corrections, retractions, or expressions of concern will be issued to preserve the integrity of the academic record. Journal policies are periodically reviewed and updated to reflect evolving ethical standards and best practices in scientific publishing.